In a nested case-control study evaluating the associations between CYP19 repeat polymorphisms and breast cancer risk, Haiman et al. [6] showed that women with the 8-repeat allele of the TTTA polymorphism have higher estrogen levels than those with the 7-repeat allele. This evidence concerns the gene CYP19A1 and breast cancer.